105 results
Page 2 of 6
8-K
EX-10.3
sdwktx1d
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
ts2cqwu3gcpsqlse5lz
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
jbost06ep36ly6w t41
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
1hcbrp
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.4
kcot5j2jyr9
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.3
cz4 7recamsgmjnnlb22
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
wxst92n0qunw8wgm5cc
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-99.1
fw7n8q6d8rp59qh wdc
28 Dec 23
Other Events
4:14pm
8-K
EX-99.1
xttak3 s78rl1t944f
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
EX-10.6
x6k03
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.1
65n7503e7
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.25
l64pi4
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.26
w81isqc4
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-10.24.1
18pbi
5 Oct 23
Index to Financial Statements
5:12pm
8-K
EX-99.2
0t02apc ybpi
5 Oct 23
Index to Financial Statements
5:12pm